You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Baxter
Express Scripts
Harvard Business School
McKinsey

Last Updated: February 20, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204851


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

NDA 204851 describes METHYLTESTOSTERONE, which is a drug marketed by Heather, Impax Labs Inc, Impax Labs, Lilly, Purepac Pharm, Pvt Form, Tablicaps, Usl Pharma, Inwood Labs, Kv Pharm, Lannett, Parke Davis, Watson Labs, and West Ward, and is included in twenty-seven NDAs. It is available from one supplier. Additional details are available on the METHYLTESTOSTERONE profile page.

The generic ingredient in METHYLTESTOSTERONE is methyltestosterone. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the methyltestosterone profile page.
Summary for 204851
Tradename:METHYLTESTOSTERONE
Applicant:Impax Labs Inc
Ingredient:methyltestosterone
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 204851
Mechanism of ActionAndrogen Receptor Agonists
Medical Subject Heading (MeSH) Categories for 204851
Suppliers and Packaging for NDA: 204851
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METHYLTESTOSTERONE methyltestosterone CAPSULE;ORAL 204851 ANDA Amneal Pharmaceuticals of New York LLC 0115-1408 0115-1408-01 100 CAPSULE in 1 BOTTLE (0115-1408-01)
METHYLTESTOSTERONE methyltestosterone CAPSULE;ORAL 204851 ANDA Amneal Pharmaceuticals of New York LLC 0115-1408 0115-1408-03 1000 CAPSULE in 1 BOTTLE (0115-1408-03)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength10MG
Approval Date:Sep 21, 2015TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Dow
Merck
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.